Ubicept, Inc. — Form D
Ubicept, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-27. The offering totals $7.8M, of which $7.8M was reported sold. Industry: Other.
Offering
- Filed: 2023-07-27
- Form: D
- Accession: 0001986281-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $7.8M
- Amount sold: $7.8M
- Investors: 16
- Date of first sale: 2023-05-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-488030
Issuer
- Name: Ubicept, Inc.
- CIK: 0001986281
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 COURT STREET, BOSTON, MA, 02108
- Phone: 617-383-9704
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Sunil Nagaraj | Director | Palo Alto, CA |
| Craig Dickman | Director | Boston, MA |
| Tristan Swedish | Director | Boston, MA |
| Tristan Swedish | Executive Officer | Boston, MA |
| Sebastian Bauer | Director | Boston, MA |
| Sebastian Bauer | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More